C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/63 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07K 7/00 (2006.01) C07K 7/04 (2006.01) C07K 14/705 (2006.01) C12N 5/06 (2006.01)
Patent
CA 2278931
Cysteine-depleted CTL epitopes can elicit a stronger or more specific CTL response than the native, cysteine-containing CTL epitope of a disease associated antigen.
Des déterminants antigéniques de lymphocytes T cytotoxiques (CTL) appauvris en cystéine peuvent déclencher une réaction de CTL plus importante ou plus spécifique que le déterminant antigénique natif de CTL contenant cystéine d'un antigène associé à une maladie.
Engelhard Victor H.
Hunt Donald F.
Kittlesen David
Slingluff Craig L.
Smart & Biggar
University Of Virginia Patent Foundation
LandOfFree
Cysteine-depleted peptides recognized by a3-restricted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cysteine-depleted peptides recognized by a3-restricted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteine-depleted peptides recognized by a3-restricted... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1481354